(Q43823864)

27 November 2017

Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome (English)

1 reference

27 November 2017

4

1 reference

27 November 2017

Yong Jiang

1

1 reference

27 November 2017

Jun Xu

2

1 reference

27 November 2017

Chengzhi Zhou

3

1 reference

27 November 2017

Shuqing Zhong

5

1 reference

27 November 2017

Jinghua Liu

6

1 reference

27 November 2017

Wei Luo

7

1 reference

27 November 2017

Tao Chen

8

1 reference

27 November 2017

Qinghe Qin

9

1 reference

27 November 2017

Peng Deng

10

1 reference

27 November 2017

language of work or name

English

0 references

publication date

18 January 2005

1 reference

American Journal of Respiratory and Critical Care Medicine

27 November 2017

1 reference

27 November 2017

171

1 reference

27 November 2017

850-857

1 reference

27 November 2017

8

1 reference

Coronavirus as a possible cause of severe acute respiratory syndrome

27 November 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-857OC

A novel coronavirus associated with severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-857OC

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-857OC

Characterization of a novel coronavirus associated with severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-857OC

The Genome sequence of the SARS-associated coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-857OC

Our strategies for fighting severe acute respiratory syndrome (SARS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-857OC

SARS-Associated Coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-857OC

The clinical pathology of severe acute respiratory syndrome (SARS): a report from China

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-857OC

Lung pathology of fatal severe acute respiratory syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-857OC

Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-857OC

Proinflammatory and anti-inflammatory cytokine responses in preterm infants with systemic infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-857OC

Inflammatory responses in influenza A virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-857OC

Chemokines--chemotactic cytokines that mediate inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-857OC

The immunopathogenesis of sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-857OC

Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-857OC

Are clinical negligence and legal action related?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-857OC

Double immunofluorescence labelling of routinely processed paraffin sections

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-857OC

What does the peripheral blood tell you in SARS?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-857OC

Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-857OC

Prolonged disturbances of in vitro cytokine production in patients with severe acute respiratory syndrome (SARS) treated with ribavirin and steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-857OC

Safety, pharmacokinetics, and pharmacodynamics of drotrecogin alfa (activated) in children with severe sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-857OC

The IFN gamma receptor: a paradigm for cytokine receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-857OC

Chemokines and chemokine receptors in inflammatory demyelinating neuropathies: a central role for IP-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-857OC

IP-10 and Mig facilitate accumulation of T cells in the virus-infected liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-857OC

Interferon-inducible protein 10, monokine induced by interferon gamma, and interferon-inducible T-cell alpha chemoattractant are produced by thymic epithelial cells and attract T-cell receptor (TCR) alphabeta+ CD8+ single-positive T cells, [...]

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-857OC

T-Cell Function and Migration — Two Sides of the Same Coin

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-857OC

The C-X-C chemokine IP-10 stimulates HIV-1 replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-857OC

Interferon-inducible protein-10 identified as a mediator of tumor necrosis in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-857OC

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-857OC

Multiple organ dysfunction syndrome: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-857OC

Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-857OC

Re-emergence of fatal human influenza A subtype H5N1 disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-857OC

Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-857OC

Management of severe acute respiratory syndrome: the Hong Kong University experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-857OC

Microbiologic characteristics, serologic responses, and clinical manifestations in severe acute respiratory syndrome, Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-857OC

Chemokines: therapeutic targets for autoimmune and inflammatory renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-857OC

SARS treatment. Interferon shows promise in monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-857OC

Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-857OC

Severe acute respiratory syndrome-related coronavirus is inhibited by interferon- alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-857OC

Viral inhibition of interferon signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-857OC

Immunology. A viral on/off switch for interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-857OC

Influenza A and Sendai Viruses Induce Differential Chemokine Gene Expression and Transcription Factor Activation in Human Macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-857OC

10.1164/RCCM.200407-857OC

21 January 2018

Identifiers

DOI

1 reference

27 November 2017

1 reference